RxDoctor Payments Data

Margot Lazow

Pediatric Hematology-Oncology · Columbus, OHNPI 1952797664

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $3,258 of the $3,258 with a category attached, or 100.0%. Day One Biopharmaceuticals accounts for 95.4% of it on its own, with 1 other manufacturer making up the rest.

$3,258in general payments, 2019–2025

Across 2 payments — averaging $1628.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Day One Biopharmaceuticals$3K
  • AstraZeneca$150
$2,456,712in research payments, 2019–2025

Across 44 payments — averaging $55,834 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$2.4M
  • Blueprint Medicines Corporation$49K
  • Regeneron$23K
  • Genentech, Inc.$10K

What the payments were for

  • Speaking & faculty fees$3,258100%

General payments by program year

19
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Day One Biopharmaceuticals1$3,108
AstraZeneca1$150

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,258 in reported general payments places this provider in the 65th percentile of 143 pediatric hematology-oncology providers in Ohio.

See all pediatric hematology-oncology providers in Ohio

Other pediatric hematology-oncology in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →